<bill session="113" type="hr" number="709" updated="2015-09-01T10:18:46-04:00">
  <state datetime="2014-07-31">REFERRED</state>
  <status>
    <introduced datetime="2014-07-31"/>
  </status>
  <introduced datetime="2014-07-31"/>
  <titles>
    <title type="official" as="introduced">Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a ''Valley of Death'' in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.</title>
  </titles>
  <sponsor id="412522"/>
  <cosponsors>
    <cosponsor id="412536" joined="2014-07-31"/>
    <cosponsor id="412403" joined="2014-07-31"/>
    <cosponsor id="400185" joined="2014-07-31"/>
    <cosponsor id="400663" joined="2014-07-31"/>
    <cosponsor id="412523" joined="2014-09-17"/>
    <cosponsor id="400350" joined="2014-07-31"/>
  </cosponsors>
  <actions>
    <action datetime="2014-07-31" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2014-08-01">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Advanced technology and technological innovations"/>
    <term name="Biological and life sciences"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Executive agency funding and structure"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Health programs administration and funding"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Medical research"/>
    <term name="Research administration and funding"/>
    <term name="Research and development"/>
  </subjects>
  <amendments/>
  <summary>7/31/2014--Introduced.
Recognizes the value of biomedicine, biotechnology, and life sciences; the challenges those industries face; and ways those challenges can be addressed.</summary>
</bill>
